Summary

Contrast Media Injectors Market Size
The global contrast media injectors market size was valued at $1.40 billion in 2024 and is projected to reach $2.27 billion by 2030, growing at a CAGR of 8.4% during the forecast period.

Contrast Media Injectors Overview
Contrast media injectors are medical devices designed for the controlled administration of contrast agents during medical imaging procedures such as computed tomography (CT) scans, magnetic resonance imaging (MRI), and angiography. These agents, often iodine-based for CT scans or gadolinium-based for MRIs, enhance the visibility of specific tissues or blood vessels, aiding in the diagnostic accuracy of the imaging study. Contrast media injectors play a crucial role in delivering these contrast agents into the patient's bloodstream at a controlled rate and volume, ensuring uniform distribution and optimal imaging results. These devices are equipped with sophisticated technologies to regulate injection parameters, such as flow rate and timing, providing healthcare professionals with the precision needed for diagnostic imaging studies. Contrast media injectors contribute to the clarity and precision of medical images, facilitating more accurate diagnoses and treatment planning in various medical specialties.

Contrast Media Injectors Market Dynamics
• The contrast media injectors market is expected to witness significant growth in the future due to the advancements in medical imaging technologies and the rising incidence of chronic diseases.
• Additionally, the increasing demand for diagnostic accuracy and the growing aging population are the prominent factors driving the growth of the contrast media injectors market.
• However, the high cost of contrast media injectors, stringent regulatory requirements, and competition from alternative imaging techniques are restraining the market growth.
• On the contrary, the technological innovations in contrast media, integration of AI in medical imaging, and expansion of diagnostic imaging centers are creating opportunities for market growth.

Impact of COVID-19 on the Contrast Media Injectors Market
The increased focus on healthcare infrastructure and the growing need for diagnostic imaging in managing COVID-19 cases have driven demand for contrast media injectors. The heightened awareness of the importance of early and accurate diagnoses has spurred investments in medical imaging technologies, contributing to the market's growth. However, the pandemic has also posed challenges, such as disruptions in the supply chain, delayed elective procedures, and financial constraints on healthcare facilities. The reduced number of non-COVID-19-related imaging studies and the temporary closure of certain healthcare facilities during lockdowns have adversely affected market revenues. Additionally, concerns about infection control and the risk of transmission have prompted changes in procedural protocols, impacting the usage patterns of contrast media injectors.

By End User, the Hospitals Segment is Expected to Witness the Highest Growth Rate during the Forecast Period
The hospitals segment is expected to witness the highest growth rate during the forecast period owing to the central role hospitals play in diagnostic imaging and patient care. Hospitals serve as major hubs for a wide range of medical procedures, including advanced imaging studies that necessitate the use of contrast media injectors. The diverse array of medical conditions treated in hospitals often requires precise and detailed diagnostic information, which contrast-enhanced imaging provides. As hospitals cater to a large and varied patient population, the need for efficient and reliable diagnostic tools, such as contrast media injectors, becomes paramount. The comprehensive services offered by hospitals, from emergency care to specialized treatments, amplify the demand for these injectors across various departments and medical specialties. The centralized management and coordination of healthcare services in hospitals make them key stakeholders in adopting advanced medical technologies, contributing significantly to the sustained demand for contrast media injectors in the hospital segment.

By Geography, the North American Region Accounted for a Major Share of the Market Revenue
North American region accounted for a major share of the market revenue due to the region's advanced healthcare infrastructure, coupled with a high prevalence of chronic diseases and a growing aging population. The continuous technological advancements in medical imaging techniques and the emphasis on early and accurate diagnoses further drive the need for contrast media injectors. Additionally, the awareness among healthcare providers and patients about the benefits of contrast-enhanced imaging studies has fueled the market's growth. North America also witnesses significant research and development activities, fostering innovation in contrast media injectors and related technologies. The well-established reimbursement framework and favorable healthcare policies contribute to the widespread adoption of these devices. Furthermore, the presence of key market players and robust collaborations between industry stakeholders and research institutions in the region further support the demand for contrast media injectors in North America.
• According to a CDC report, the United States is witnessing a rising incidence of heart failure, positioning it as a prominent cause of mortality. In 2020, cardiovascular diseases accounted for approximately 659,000 deaths in the U.S., underlining the significant public health impact. The forecast for 2030 suggests a projected 46.0% increase in the number of individuals affected by heart diseases. These medical devices play a pivotal role in advanced diagnostic imaging, aiding in the early identification and management of cardiovascular issues, aligning with the imperative to address the escalating health challenges associated with heart-related conditions.

Key Target Audience:
• Healthcare Providers and Institutions
• Diagnostic Imaging Centers
• Pharmaceutical and Medical Device Companies
• Regulatory Authorities and Compliance Agencies
• Research and Academic Institutions
• Patients and Patient Advocacy Groups
• Health Insurance Companies
• Investors and Financial Institutions

List of the Key Players Profiled in the Report Includes:
• Bayer Ag
• APOLLO RT Co. Ltd.
• Ulrich GmbH & Co. KG
• Sino Medical-Device Technology Co., Ltd.
• Shenzhen Anke High-tech Co. Ltd
• Shenzen Seacrown Electromechanical Co Ltd.
• Nemoto Kyorindo Co., Ltd
• Medtron AG RT Co. Ltd.
• Guerbet Group
• Bracco Imaging S.P.A

Recent Developments:
• In January 2023, Bayer announced the approval of its iodine-based contrast agent, Ultravist™-300, -370, for contrast-enhanced mammography (CEM) in the EU. This product is now authorized for assessing and detecting breast lesions, serving as a supplement to mammography (with or without ultrasound) or as an alternative in cases where magnetic resonance imaging (MRI) is not feasible or contraindicated. With the approval granted through the European Workshare Procedure, the first national approvals within the EU are anticipated in the first quarter of 2023. CEM represents a growing modality merging digital mammography with contrast agent administration, like Ultravist, to aid in breast cancer diagnosis and treatment guidance. This approval marks an expansion of Bayer's radiology portfolio, encompassing contrast media, injectors, digital solutions, and artificial intelligence (AI) technologies, all of which support radiologists in diagnosing a wide spectrum of diseases, including breast cancer.
• In November 2022, Bayer announced its extensive Radiology portfolio, showing progress in the development pipeline of novel contrast agents and forging additional partnerships in its digital business. Furthermore, Bayer has unveiled three collaboration agreements for its digital platform, Calantic™ Digital Solutions, along with an AI accelerator program. These initiatives underscore Bayer's dedication to fostering innovations that provide benefits to patients and healthcare professionals. The focus extends to harnessing the substantial potential of artificial intelligence (AI) in enhancing medical solutions and patient care.

Market Segmentation:
The research report includes in-depth coverage of the industry analysis with size, share, and forecast for the below segments:

Market by, Product Type:
• Injector Systems
• Consumables

Market by, Application:
• Interventional Cardiology
• Interventional Radiology
• Radiology

Market by, End User:
• Ambulatory Surgery Centers
• Diagnostics Imaging Centers
• Hospitals

Market by, Geography:
The contrast media injectors market report also analyzes the major geographic regions and countries of the market. The regions and countries covered in the study include:
• North America (The United States, Canada, Mexico), Market Estimates, Forecast & Opportunity Analysis
• Europe (Germany, France, UK, Italy, Spain, Rest of Europe), Market Estimates, Forecast & Opportunity Analysis
• Asia Pacific (China, Japan, India, South Korea, Australia, New Zealand, Rest of Asia Pacific), Market Estimates, Forecast & Opportunity Analysis
• South America (Brazil, Argentina, Chile, Rest of South America), Market Estimates, Forecast & Opportunity Analysis
• Middle East & Africa (UAE, Saudi Arabia, Qatar, Iran, South Africa, Rest of Middle East & Africa), Market Estimates, Forecast & Opportunity Analysis

What Can be Explored with this Research Report:
• Understand the key trends that will drive the market and the challenges it faces in the current market scenario
• Identify growth opportunities
• Porter’s five force analysis
• In-depth analysis of market segments, and regions/countries predicted to observe promising growth
• Historical and forecast size of the market in terms of revenue (USD Million)
• Company profiling with key products and solution offerings, key financial information, SWOT analysis, and business strategies adopted

ページTOPに戻る

Table of Contents

1 Market Introduction
1.1 Market Definition
1.2 Research Scope and Segmentation
1.3 Stakeholders
1.4 List of Abbreviations

2 Executive Summary

3 Research Methodology

4 Market Dynamics
4.1 Market Drivers
4.2 Market Restraints
4.3 Market Opportunities
4.4 Market Challenges
4.5 Impact of COVID-19 on the Contrast Media Injectors Market

5 Porter's Five Force Analysis
5.1 Bargaining Power of Suppliers
5.2 Bargaining Power of Buyers
5.3 Threat of New Entrants
5.4 Threat of Substitutes
5.5 Competitive Rivalry in the Market

6 Global Contrast Media Injectors Market by, Product Type
6.1 Overview
6.2 Injector Systems
6.2.1 Computed Tomography (CT) Injectors
6.2.2 Magnetic Resonance Imaging (MRI) Injectors
6.2.3 Angiography Injectors
6.2.4 Accessories
6.3 Consumables
6.3.1 Tubes
6.3.2 Syringes

7 Global Contrast Media Injectors Market by, Application
7.1 Overview
7.2 Interventional Cardiology
7.3 Interventional Radiology
7.4 Radiology

8 Global Contrast Media Injectors Market by, End User
8.1 Overview
8.2 Ambulatory Surgery Centers
8.3 Diagnostics Imaging Centers
8.4 Hospitals

9 Global Contrast Media Injectors Market by, Geography
9.1 Overview
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 France
9.3.3 UK
9.3.4 Italy
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 South Korea
9.4.5 Australia
9.4.6 New Zealand
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 UAE
9.6.2 Saudi Arabia
9.6.3 Qatar
9.6.4 Iran
9.6.5 South Africa
9.6.6 Rest of Middle East & Africa

10 Key Developments

11 Company Profiling
11.1 Bayer Ag
11.1.1 Business Overview
11.1.2 Product/Service Offering
11.1.3 Financial Overview
11.1.4 SWOT Analysis
11.1.5 Key Activities
11.2 APOLLO RT Co. Ltd.
11.3 Ulrich GmbH & Co. KG
11.4 Sino Medical-Device Technology Co., Ltd.
11.5 Shenzhen Anke High-tech Co. Ltd
11.6 Shenzen Seacrown Electromechanical Co Ltd.
11.7 Nemoto Kyorindo Co., Ltd
11.8 Medtron AG RT Co. Ltd.
11.9 Guerbet Group
11.10 Bracco Imaging S.P.A